FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
23,173,131
Share change
+1,015,284
Total reported value
$941,398,135
Put/Call ratio
445%
Price per share
$40.63
Number of holders
139
Value change
+$39,798,681
Number of buys
79
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2016

As of 31 Mar 2016, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 139 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,173,131 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, EVENTIDE ASSET MANAGEMENT, LLC, Versant Venture Management, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, DEERFIELD MANAGEMENT CO, and RS INVESTMENT MANAGEMENT CO LLC. This page lists 139 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.